Immunotherapy has proven to be effective against many serious diseases. But to treat diseases in the brain, the antibodies must first get past the obstacle of the blood-brain barrier. In a new study, a research group at Uppsala University describes their development of a new antibody design that increases brain uptake of antibodies almost 100-fold.
from Dementia Big http://ift.tt/2jYtBfz via alcoholic dementia
http://ift.tt/2jDf3ij
No comments:
Post a Comment